Body Composition and Fatty Liver Disease

This study investigates relationship between fatty liver prognosis and body composition analysis result based on non-contrast low dose CT in patients with fatty liver disease.

Inclusion Criteria:metabolic dysfunction-associated fatty liver disease (fatty liver with overweight/obesity, or type II DM or other metabolic dysfunction)or non-alcoholic fatty liver disease with liver function test abnormalitysigned informed consentExclusion Criteria:chronic hepatitis B or Cother disease related to fatty liver such as glycogen storage disease, lipodystrophy, familial combined hyperlipidemia, hypobetalipoproteinemia, Weber-Christian syndrome or abetalipoproteinemiaon medication related to hepatic steatosis (tamoxifen, steroid, valproic acid, methotrexate, amiodarone)diabetes after pancreatectomyhistory of total parenteral nutrition in 6 monthspregnancy or nursing mother